Dr. Rishi Chadha, MD is a board‑certified gastroenterologist who specializes in preventive gastroenterology, colorectal cancer screening, and minimally invasive endoscopic procedures. He completed his fellowship at Sunrise Health GME in Las Vegas and previously trained in internal medicine at St. Vincent’s Medical Center in Connecticut.
Nonalcoholic Steatohepatitis (NASH) is a form of fatty liver disease in which excess fat buildup in the liver leads to inflammation, liver cell damage, and scarring. It occurs in people who drink little to no alcohol. If left untreated, NASH can progress to cirrhosis and liver failure. Early detection and lifestyle changes can halt or reverse disease progression.
Dr. Chadha reviews your personal and family medical history, alcohol use, medications, and risk factors�then performs a targeted physical exam.
We measure liver enzymes and other blood markers to assess liver function and rule out alternate causes of liver injury.
Dr. Chadha applies validated scoring systems (e.g., NAFLD Fibrosis Score) to estimate the degree of liver scarring.
In uncommon or uncertain cases, a liver biopsy provides definitive grading of inflammation and fibrosis.
Dr. Rishi Chadha, MD is a board‑certified gastroenterologist who specializes in preventive gastroenterology, colorectal cancer screening, and minimally invasive endoscopic procedures. He completed his fellowship at Sunrise Health GME in Las Vegas and previously trained in internal medicine at St. Vincent’s Medical Center in Connecticut.
Nonalcoholic Steatohepatitis (NASH) is a form of fatty liver disease not caused by alcohol. Fat builds up in the liver, leading to inflammation, cell damage, and scarring.
Key risk factors include obesity or rapid weight gain, type 2 diabetes or prediabetes, high cholesterol or triglycerides, metabolic syndrome, PCOS, and certain medications (e.g., steroids).
Many people have no symptoms. Others may experience fatigue, mild pain in the upper right abdomen, unplanned weight loss, or elevated liver enzymes on blood tests.
The ICD-10 code for Nonalcoholic Steatohepatitis is K75.81.
Simple fatty liver (NAFL) involves fat accumulation without damage. NASH includes inflammation and scarring, increasing the risk of progression to cirrhosis.
Yes�when caught early, NASH can be halted or even reversed through gradual weight loss (5�10% of body weight), a healthy diet, and regular exercise.
Diagnosis may involve blood tests for liver enzymes, ultrasound or FibroScan� to assess fat and stiffness, noninvasive scoring systems, and'rarely�a liver biopsy.
Avoid sugary drinks, processed foods, refined carbohydrates (white bread, pastries), and snacks high in added sugars and unhealthy fats.
No. Dr. Chadha begins with noninvasive tests and uses biopsy only when results are unclear or advanced liver scarring is suspected.
Call GastroDoxs to schedule a consultation with Dr. Rishi Chadha. He'll create a personalized liver-health plan tailored to your needs.
